How Much Weight Do You Lose with Wegovy?

Last reviewed: June 22, 2026

Last updated: June 22, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Wegovy, the brand-name injectable semaglutide, achieved FDA approval for chronic weight management based on clinical trials showing patients lost between 15% and 22% of their starting body weight over 68 weeks. Most people experience gradual weight loss beginning in weeks 2–4, with the most dramatic results occurring after 4–6 months of consistent treatment. PlexusDx provides compounded semaglutide injection from licensed 503A pharmacies, delivering the same active medication at significantly lower cost.

How Much Weight Do Semaglutide Users Typically Lose?

The landmark STEP 4 clinical trial tracked 902 adults taking semaglutide weekly injections over 68 weeks. Participants randomized to the highest dose (2.4 mg weekly) achieved an average body weight reduction of 22.1% compared to their baseline, while those on placebo lost only 2.6%. This 20-percentage-point difference represents substantial clinical benefit: a 250-pound person would expect to lose approximately 50 pounds, while a 200-pound person would lose roughly 44 pounds.

Individual results vary based on starting weight, adherence to treatment, diet quality, exercise frequency, and genetic factors. Some patients reach their target weight in 6 months; others require 12–18 months of therapy. Weight loss typically plateaus after 12 months unless additional medication adjustments are made, though most people maintain their reduced weight as long as they continue semaglutide injections.

What Timeline Should You Expect for Weight Loss?

Semaglutide works by slowing stomach emptying and activating satiety signals in the brain, reducing hunger and overall calorie intake. During the first 4 weeks at lower starting doses (0.25 mg), most patients report decreased appetite but may see minimal scale changes—this is normal and expected. By week 8–12, as doses escalate to 0.5 mg and then 1 mg, meaningful weight loss typically becomes visible: 3–8 pounds is common during this period.

Weeks 13–26 represent the steepest weight loss phase for many people, with monthly reductions of 2–4 pounds on average. After 26 weeks, the rate of weight loss usually slows but remains positive. Reaching your personal goal weight typically requires 12–24 weeks of treatment at therapeutic doses (1.7–2.4 mg weekly), though this timeline extends for people with higher starting weights or genetic resistance to GLP-1 receptor activation.

Genetic Factors That Influence Your Weight Loss Response

Not everyone responds identically to semaglutide because genetic variations affect how your body produces and responds to GLP-1 and related weight-regulation peptides. The PlexusDx Precision Peptide Genetic Test analyzes 14 metabolic pathways across 49 peptides to identify your individual response profile. Key genetic markers include the GLP1R rs6923761 variant (which influences GLP-1 receptor sensitivity) and the FTO rs9939609 variant (which modulates appetite set-point and fat accumulation patterns).

Patients with favorable GLP-1 pathway genetics may experience rapid weight loss within the first 8 weeks and sustain losses exceeding 25% of body weight. Those with genetic variants suggesting reduced GLP-1 receptor responsiveness may benefit from dose escalation, longer treatment duration, or dual-compound protocols combining semaglutide with tirzepatide. The Precision Peptide test costs $99 as an add-on after your first month of treatment, allowing PlexusDx clinicians to personalize your medication strategy based on your genetic blueprint.

Compounded Semaglutide vs. Wegovy: Cost and Access

Brand-name Wegovy typically costs $1,500–$1,800 per monthly injection at retail price, placing it out of reach for many patients without insurance coverage. PlexusDx compounded semaglutide injection starts at $149 per month across all three commitment tiers, with flat pricing regardless of your dose strength—your dose may need to go up, but your price will not. All PlexusDx medications are manufactured by licensed 503A compounding pharmacies, meet pharmaceutical standards for sterility and potency, and remain available in all 50 states without insurance or membership fees.

Both compounded and brand-name semaglutide contain the same active ingredient and require weekly subcutaneous injection. The primary difference is cost: PlexusDx patients save $1,200–$1,600 monthly compared to brand prices. Treatment is HSA and FSA eligible, further reducing out-of-pocket expenses. PlexusDx also offers oral semaglutide (starting at $249/mo) for patients who prefer tablets over injections, though injectable forms typically deliver faster and more consistent weight loss.

When to Expect Results and How to Maximize Weight Loss

Meaningful weight loss becomes noticeable after 8–12 weeks of treatment at therapeutic doses, but some people observe appetite suppression and minor scale changes within 2–4 weeks. Consistency matters: missing injections or extending intervals beyond 7 days reduces drug effectiveness and slows weight loss. Pairing semaglutide with a protein-rich diet (25–35% of daily calories) and regular physical activity (150 minutes of moderate cardio weekly) accelerates results and improves body composition—you lose more fat and preserve more lean muscle.

Many patients hit a weight-loss plateau after 4–6 months at a single dose. This is when dose escalation (moving from 1.0 mg to 1.7 mg or 2.4 mg weekly) often reignites weight loss. Others may benefit from the GLP-Squared Injection protocol, which combines compounded semaglutide and tirzepatide for synergistic appetite suppression and metabolic enhancement. PlexusDx clinicians assess your genetic test results and response history to recommend the optimal next step when progress stalls.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Can I expect the same weight loss results with compounded semaglutide as with brand-name Wegovy?

Yes. Compounded semaglutide and Wegovy contain identical active pharmaceutical ingredients and produce equivalent weight loss when dosed correctly. Both typically deliver 15–22% body weight reduction over 68 weeks. The difference is cost: PlexusDx compounded semaglutide starts at $149/month versus $1,500–$1,800 for Wegovy. Both are administered as once-weekly subcutaneous injections.

How fast will I lose weight on semaglutide?

Weight loss accelerates gradually: weeks 1–4 may show minimal changes as your body adjusts to appetite suppression, but weeks 8–12 typically reveal 3–8 pounds of loss. Peak weight loss velocity occurs weeks 13–26, when many patients lose 2–4 pounds monthly. After month 6, the rate slows but continues until you reach your goal, usually within 12–24 weeks of therapy at full therapeutic doses (1.7–2.4 mg weekly).

Is compounded semaglutide from licensed pharmacies safe and legal?

PlexusDx sources all compounded medications from licensed 503A compounding pharmacies that meet FDA standards for sterility, potency, and quality. These pharmacies operate under state pharmacy board oversight and federal regulations. While compounded semaglutide is not FDA-approved as a brand medication, it is legally permitted and widely prescribed by clinicians across the United States.

What if I stop seeing weight loss results after a few months?

Weight-loss plateaus are common and typically occur 4–6 months into treatment. PlexusDx clinicians often recommend increasing your dose to the next level (for example, from 1.0 mg to 1.7 mg weekly), which reignites weight loss in most patients. Others may qualify for the GLP-Squared Injection protocol, which combines semaglutide and tirzepatide for enhanced metabolic effect. Your Precision Peptide Genetic Test results guide these personalized adjustments.

How does the PlexusDx Precision Peptide Genetic Test help predict my weight loss?

The test analyzes genetic variants in GLP-1 receptor pathways, FTO (fat mass and obesity-related gene), and 12 additional metabolic pathways to predict your individual response to semaglutide and tirzepatide. Patients with favorable GLP-1R genetics may achieve 25%+ weight loss, while those with reduced-sensitivity variants may benefit from dose escalation or dual-compound protocols. The $99 test (added after month one) personalizes your treatment roadmap.

Related Reading

• Can My Dna Tell Me How Do You Lose Weight
• Can A Dna Test Tell Me How Do You Lose Weight
• Can You Get A Dna Test To See How Do You Lose Weight
• Wegovy For Losing Weight

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.